Global elimination of trachoma: How frequently should we administer mass chemotherapy?

Citation
T. Lietman et al., Global elimination of trachoma: How frequently should we administer mass chemotherapy?, NAT MED, 5(5), 1999, pp. 572-576
Citations number
51
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Journal title
NATURE MEDICINE
ISSN journal
10788956 → ACNP
Volume
5
Issue
5
Year of publication
1999
Pages
572 - 576
Database
ISI
SICI code
1078-8956(199905)5:5<572:GEOTHF>2.0.ZU;2-P
Abstract
The World Health Organization has recommended repeat mass drug administrati on as part of their global initiative to eliminate blinding trachoma by the year 2020. The efficacy of repeat treatment will be tested empirically, bu t the results will not be available for many years, and recommendations for the necessary frequency of treatment are needed immediately. We have devel oped a mathematical model that uses available epidemiological data from a v ariety of countries. We recommend, based on our analysis, that in areas whe re trachoma is moderately prevalent (<35% in children), it should be treate d annually, but hyperendemic areas (>50% in children), it should be treated biannually.